Journal
NEURON
Volume 68, Issue 3, Pages 428-441Publisher
CELL PRESS
DOI: 10.1016/j.neuron.2010.10.020
Keywords
-
Categories
Funding
- NIH [AG011385, AG022074]
- McBean Foundation
Ask authors/readers for more resources
The entorhinal cortex (EC) is one of the earliest affected, most vulnerable brain regions in Alzheimer's disease (AD), which is associated with amyloid-beta (A beta) accumulation in many brain areas. Selective overexpression of mutant amyloid precursor protein (APP) predominantly in layer II/III neurons of the EC caused cognitive and behavioral abnormalities characteristic of mouse models with widespread neuronal APP overexpression, including hyperactivity, disinhibition, and spatial learning and memory deficits. APP/A beta overexpression in the EC elicited abnormalities in synaptic functions and activity-related molecules in the dentate gyrus and CA1 and epileptiform activity in parietal cortex. Soluble A beta was observed in the dentate gyrus, and A beta deposits in the hippocampus were localized to perforant pathway terminal fields. Thus, APP/A beta expression in EC neurons causes transsynaptic deficits that could initiate the cortical-hippocampal network dysfunction in mouse models and human patients with AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available